Recent Advances in Cervical Cancer Treatment
healthbook TIMES. Oncology Hematology(2024)
Abstract
Cervical cancer refers to the malignant transformation of cervical epithelial or glandular cells, primarily attributed to persistent infection with high-risk human papillomavirus (HPV) genotypes. Recurrent or metastatic cervical cancer is characterized by an unfavorable prognosis and a high mortality rate. Although incorporating the anti-angiogenic agent bevacizumab into treatment protocols has led to enhanced survival rates, a significant number of patients with disease progression following initial platinum-based chemotherapy have limited therapeutic options. This paper aims to provide an overview of the current progress in cervical cancer treatment strategies, with a focus on the most relevant, potentially practice-changing results of recent phase III clinical trials.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined